MMJ Group Holdings Ltd (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail.
Cann Global Limited (ASX:CGB) is pleased to advise that the company is in the process of providing the ASX with all the paperwork confirming completion of all the transactions, completion of all the share issues, receipt of all the required escrow agreements, and the related required relisting documentation.
MMJ Group Holdings Limited (ASX:MMJ)(ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) is pleased to announce it will be hosting a live audio webcast of the Investor Conference Call on 17 July 2019.
THC Global Group Limited (ASX:THC)(OTCMKTS:HDRPF) is pleased to advise that the Company's wholly owned subsidiary, THC Pharma Pty Ltd, has been granted a Manufacture Licence from the Australian Office of Drug Control for its Southport Manufacturing Facility.
MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) provides the MMJ Investment Portfolio Report as at 31 May 2019. This report includes details of MMJ's net tangible asset per share as at 31 May 2019 pursuant to Listing Rule 4.12 as a listed investment company.
THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) is pleased to advise that THC Global, through its wholly owned subsidiary Canndeo Limited, has been granted a Manufacture Licence for the production of extracts and tinctures of cannabis and cannabis resin from the Australian Office of Drug Control.
MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) is pleased to announce an on-market buy-back of up to 10m MMJ ordinary shares over the next 12 months ('buy-back') as part of its active approach to capital management.
